Chapter 29. Forskolin and Adenylate Cyclase: New Opportunities in Drug Design
- 1 January 1984
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- Adenosine 3′,5′-monophosphate and testosterone responses of normal and desensitized Leydig cells to forskolinLife Sciences, 1983
- Muscarinic cholinergic inhibition of cyclic AMP formation and adrenocorticotropin secretion in mouse pituitary tumor cellsBiochemical and Biophysical Research Communications, 1983
- FORSKOLIN LOWERS INTRAOCULAR PRESSURE IN RABBITS, MONKEYS, AND MANThe Lancet, 1983
- Cerebral endothelial cell culture II. Adenylate cyclase response to prostaglandins and their interaction with the adrenergic systemLife Sciences, 1983
- Desensitization of the D-2 dopamine receptor and the β2-adrenoceptor in the intermediate lobe of the rat pituitary glandNeurochemistry International, 1982
- Multireceptor-induced release of adrenocorticotropin from anterior pituitary tumor cellsBiochemical and Biophysical Research Communications, 1982
- Alpha-2 adrenergic activation inhibits forskolin-stimulated adenylate cyclase activity and lipolysis in human adipocytesLife Sciences, 1982
- Forskolin as a novel lipolytic agentBiochemical and Biophysical Research Communications, 1982
- Forskolin potentiates adrenocorticotropin-induced cyclic AMP production and steroidogenesis in isolated rat adrenal cellsLife Sciences, 1982
- Forskolin stimulates cyclic AMP synthesis, lowers intraocular pressure and increases outflow facility in rabbitsCurrent Eye Research, 1982